SDS

Not available.
May cause damage to organs through prolonged or repeated exposure.
General
:
Suspected of causing cancer. Risk of cancer depends on duration and level of
exposure.
Carcinogenicity
:
No known significant effects or critical hazards.
Mutagenicity
:
Suspected of damaging the unborn child.
Teratogenicity
:
Developmental effects
:
No known significant effects or critical hazards.
Fertility effects
:
Suspected of damaging fertility.
Symptoms related to the physical, chemical and toxicological characteristics
Skin contact
Ingestion
Inhalation
Adverse symptoms may include the following:
respiratory tract irritation
coughing
nausea or vomiting
headache
drowsiness/fatigue
dizziness/vertigo
unconsciousness
reduced fetal weight
increase in fetal deaths
skeletal malformations
Adverse symptoms may include the following:
nausea or vomiting
reduced fetal weight
increase in fetal deaths
skeletal malformations
Adverse symptoms may include the following:
irritation
redness
reduced fetal weight
increase in fetal deaths
skeletal malformations
:
:
:
Eye contact
:
Adverse symptoms may include the following:
pain or irritation
watering
redness
Potential chronic health effects
Delayed and immediate effects and also chronic effects from short and long term exposure
Numerical measures of toxicity
Oral
3063.3 mg/kg
Route
ATE value
Acute toxicity estimates
Potential immediate
effects
:
Not available.
Short term exposure
Potential delayed effects
:
Not available.
Potential immediate
effects
:
Not available.
Long term exposure
Potential delayed effects
:
Not available.
Date of issue/Date of revision
:
8/2/2016
Date of previous issue
:
6/4/2016
Version
:
2.01
12/16